Exon-Skipping Antisense Oligonucleotides to Correct Missplicing in Neurogenetic Diseases
Open Access
- 1 February 2014
- journal article
- review article
- Published by SAGE Publications in Nucleic Acid Therapeutics
- Vol. 24 (1) , 69-86
Abstract
Alternative splicing is an important regulator of the transcriptome. However, mutations may cause alteration of splicing patterns, which in turn leads to disease. During the past 10 years, exon skipping has been looked upon as a powerful tool for correction of missplicing in disease and progress has been made towards clinical trials. In this review, we discuss the use of antisense oligonucleotides to correct splicing defects through exon skipping, with a special focus on diseases affecting the nervous system, and the latest stage achieved in its progress.Keywords
This publication has 131 references indexed in Scilit:
- Splicing therapy for neuromuscular diseaseMolecular and Cellular Neuroscience, 2013
- Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin SynthesisNeuron, 2012
- Antisense-Mediated Exon Inclusion2012
- Functional characterization and targeted correction of ATM mutations identified in Japanese patients with ataxia-telangiectasiaHuman Mutation, 2011
- Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation studyThe Lancet, 2011
- Tau splicing and the intricacies of dementiaJournal of Cellular Physiology, 2011
- Barriers to Non-Viral Vector-Mediated Gene Delivery in the Nervous SystemPharmaceutical Research, 2011
- Functional and Evolutionary Insights into Human Brain Development through Global Transcriptome AnalysisNeuron, 2009
- Antisense inhibition at the β-secretase-site of β-amyloid precursor protein reduces cerebral amyloid and acetyl cholinesterase activity in Tg2576Neuroscience, 2007
- Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucleotideThe Journal of Gene Medicine, 2005